Subgroup analysis in MCI patients positive to amyloid showed that GFAP (β=-1.32, p = 0.016) and NfL (β=-1.84, p < 0.001) significantly predicted cognitive decline, whilst for other biomarkers no significant interactions were found. This evidence concerns the gene NEFL and Mental deterioration.